North America Leukapheresis Market
No. of Pages: 118 | Report Code: TIPRE00025789 | Category: Life Sciences
No. of Pages: 118 | Report Code: TIPRE00025789 | Category: Life Sciences
The North American Leukapheresis market is analyzed based on three large countries: the United States, Canada, and Mexico. The US region is contributing a major share in the growth of leukapheresis market. According to the 2017 United Nations Aging Report, there were 962 million people around the world who were 60 years of age or older, and the number is expected to reach nearly 2.1 billion by 2050. The number of Americans aged 65 and over is projected to more than double from 46 million in 2016 to over 98 million in 2060. The proportion of the world population aged 65 and over is expected to increase by 15 percent. Hyperleukocytosis in AML with leukostasis is a serious life-threatening disease with high early mortality and requires immediate cytoreductive therapy. The American Society of Apheresis currently recommends therapeutic leukapheresis in patients with a white blood cell count> 100 G / L with signs of leukostasis. The Transfusion Medical Service will perform apheresis in most United States medical centers where this therapeutic modality is available. Strict rules govern how the procedures are carried out and who is allowed to carry them out (i.e., level of training and supervision). Therefore, the blood bank is appropriate for the entire harvesting process of the peripheral blood stem, as it is basically a variant of leukapheresis. In addition, since the product's processing and storage usually take place in the blood bank, the entire process is kept under the supervision of one unit, which makes quality control considerably easier. According to the American Cancer Society, 60,530 new cases of all types of leukemia were diagnosed in 2020, with 23,100 deaths recorded. Acute myeloid leukemia is the most common in the US, with 19,940 cases. In addition, research and development and new technological advances are other factors driving the market growth.
North America has been witnessing a growing number of COVID-19 cases since its outbreak. The cases are also increasing in Mexico. In Mexico. At present, the majority of the diagnostic laboratories and research institutes are engaged in diagnosing the COVID-19 patients. Currently, the COVID-19 diagnostic testing industry is witnessing upsurge on account of a growing number of cases coupled with the increasing emergency use authorizations from the regulatory bodies. In addition, With the WHO declaring the COVID-19 outbreak a pandemic, a mix of established pharmaceutical and biopharmaceutical companies and small startups have stepped forward to develop treatments that target the infection. The U.S. Food and Drug Administration issued an emergency use authorization for a blood purification system to treat patients 18 years of age or older with confirmed Coronavirus Disease 2019 (COVID-19) admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure. The FDA issued this emergency use authorization to Terumo BCT Inc. and Marker Therapeutics AG for their Spectra Optia Apheresis System and Depuro D2000 Adsorption Cartridge devices.
Strategic insights for the North America Leukapheresis provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 28.54 Million |
| Market Size by 2028 | US$ 52.65 Million |
| Global CAGR (2021 - 2028) | 9.1% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The geographic scope of the North America Leukapheresis refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The leukapheresis market in North America is expected to grow from US$ 28.54 million in 2021 to US$ 52.65 million by 2028; it is estimated to grow at a CAGR of 9.1% from 2021 to 2028. The incidence of blood-related disorders is rising in developing countries due to the shift in lifestyle owing to the adoption of modern facilities. The modernization of facilities has led to reduction in physical activities of people, unlike stress levels, which are increasing due to various professional and personal factors. Developing countries are significantly focusing on the advancement of their healthcare facilities. For example, Hemophilia Federation (HFI) is a nonprofit organization that has worked closely with the World Federation of Hemophilia (WFH) to spread awareness and educate people regarding affordable treatments available for hemophilia, thereby improving diagnosis and therapy. Thus, the abovementioned factors are providing opportunities for the growth of the leukapheresis market.
In terms of product type, the leukapheresis disposables segment held a larger share in 2021. Based on application, research applications segment held the largest share in 2021. Based on end user, blood component providers and blood centers segment held the largest share in 2021.
A few major primary and secondary sources referred to for preparing this report on the leukapheresis market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Asahi Kasei Corporation; Fresenius SE & Co. KGaA; Haemonetics Corporation; Terumo Corporation; STEMCELL Technologies Inc.; HemaCare; Macopharma; AllCells; STEMEXPRESS; and BioIVT among others.
The North America Leukapheresis Market is valued at US$ 28.54 Million in 2021, it is projected to reach US$ 52.65 Million by 2028.
As per our report North America Leukapheresis Market, the market size is valued at US$ 28.54 Million in 2021, projecting it to reach US$ 52.65 Million by 2028. This translates to a CAGR of approximately 9.1% during the forecast period.
The North America Leukapheresis Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Leukapheresis Market report:
The North America Leukapheresis Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Leukapheresis Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Leukapheresis Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Leukapheresis Market
